Medical Director of Digestive Health Center Northwestern University Feinberg School of Medicine Northwestern University Feinberg School of Medicine Chicago, Illinois
This activity is supported by an independent educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
Learning Objectives:
Summarize the role of IL-12 and IL-23 pathways in inflammatory bowel disease pathogenesis
Describe the rationale for a treat-to-target strategy when caring for patients with inflammatory bowel disease
Evaluate key efficacy and safety data for IL-12/23 and IL-23 inhibitors in the treatment of inflammatory bowel disease